Cormorant Asset Management, LP

Holdings History for Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT)

Symbol: SRPT on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2024		-1.1%	$0	0	-125,000	-100%	$18.50	Q3 2024
30 Jun 2024	1.1%	+0.87%	$19,750,000	125,000	+125,000	NEW	$158.00	Q2 2024
30 Sep 2023		-0.85%	$0	0	-130,000	-100%	$18.50	Q3 2023
30 Jun 2023	0.85%	+0.13%	$14,887,600	130,000	+20,000	+18%	$114.52	Q2 2023
31 Mar 2023	1%	-0.82%	$15,161,000	110,000	-90,000	-45%	$137.83	Q1 2023
31 Dec 2022	1.7%	0%	$25,916,000	200,000	0		$129.58	Q4 2022
30 Sep 2022	1.6%	+1.6%	$22,108,000	200,000	+200,000	NEW	$110.54	Q3 2022
30 Jun 2021		-0.15%	$0	0	-70,000	-100%	$18.50	Q2 2021
31 Mar 2021	0.15%	0%	$5,217,000	70,000	0		$74.53	Q1 2021
31 Dec 2020	0.35%	-0.07%	$11,934,000	70,000	-15,000	-18%	$170.49	Q4 2020
30 Sep 2020	0.53%	-0.15%	$11,937,000	85,000	-25,000	-23%	$140.44	Q3 2020
30 Jun 2020	0.77%	-0.28%	$17,637,000	110,000	-40,000	-27%	$160.34	Q2 2020
31 Mar 2020	0.84%	-0.56%	$14,673,000	150,000	-100,000	-40%	$97.82	Q1 2020
31 Dec 2019	1.4%	+0.16%	$32,260,000	250,000	+28,300	+13%	$129.04	Q4 2019
30 Sep 2019	1.2%	-0.02%	$16,698,000	221,700	-3,300	-1.5%	$75.32	Q3 2019
30 Jun 2019	2.2%	-0.72%	$34,189,000	225,000	-75,000	-25%	$151.95	Q2 2019
31 Mar 2019	2.6%	+1.8%	$35,757,000	300,000	+210,000	+233%	$119.19	Q1 2019
31 Dec 2018	0.89%	+0.89%	$9,822,000	90,000	+90,000	NEW	$109.13	Q4 2018

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.